Commerce Department, Industry and Security Bureau
This notice announces the procedures for companies that manufacture pharmaceutical products to apply for company-specific agreements with the Department of Commerce (Commerce) to onshore manufacturing of pharmaceutical products and their ingredients. Companies that enter into such agreements are eligible for a reduced Section 232 duty rate for imports of their pharmaceutical products and associated ingredients. Companies are requested to submit applications within 30 days of publication in the Federal Register.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Commerce Bureau of Industry and Security [Docket No. 260428-0115] X-RIN 0694-XC155 AGENCY: Bureau of Industry and Security, Office of Strategic Industries and Economic Security, U.S. Department of Commerce. ACTION: Notice. SUMMARY: This notice announces the procedures for companies that manufacture pharmaceutical products to apply for company-specific agreements with the Department of Commerce (Commerce) to onshore manufacturing of pharmaceutical products and their ingredients. Companies that enter into such agreements are eligible for a reduced Section 232 duty rate for imports of their pharmaceutical products and associated ingredients. Companies are requested to submit applications within 30 days of publication in the Federal Register . DATES: Applications are requested by June 12, 2026. ADDRESSES: Applications must be submitted electronically to: pharma232@bis.doc.gov . Applications can be found at www.bis.gov/​about-bis/​bis-leadership-and-offices/​SIES/​section-232-investigations . FOR FURTHER INFORMATION CONTACT: Stephen Astle, Director, Defense Industrial Base Division, Office of Strategic Industries and Economic Security, Bureau of Industry and Security, U.S. Department of Commerce (202) 482-4506, pharma232@bis.doc.gov . SUPPLEMENTARY INFORMATION: I. Background On April 2, 2026, the President issued Proclamation 11020 ( 91 FR 18183 ), “Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United State…
Citation: 91 FR 26989
